Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4203)
All Articles published online
|
Jan 7, 2006 (publication date) through Dec 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Guo Q, Tang W, Inagaki Y, Midorikawa Y, Kokudo N, Sugawara Y, Nakata M, Konishi T, Nagawa H, Makuuchi M. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. World J Gastroenterol 2006; 12(1): 54-59 [PMID: 16440417 DOI: 10.3748/wjg.v12.i1.54] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Guo Q, Tang W, Inagaki Y, Midorikawa Y, Kokudo N, Sugawara Y, Nakata M, Konishi T, Nagawa H, Makuuchi M. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. World J Gastroenterol 2006; 12(1): 54-59 [PMID: 16440417 DOI: 10.3748/wjg.v12.i1.54] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i1/54.htm |
| Number | Citing Articles |
| 1 |
Takahiko Matsushita, Naoki Ohyabu, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Hiroshi Hinou, Shin-Ichiro Nishimura. Site-Specific Conformational Alteration Induced by Sialylation of MUC1 Tandem Repeating Glycopeptides at an Epitope Region for the Anti-KL-6 Monoclonal Antibody. Biochemistry 2013; 52(2): 402 doi: 10.1021/bi3013142
|
| 2 |
Huan-Li Xu, Xin Zhao, Ke-Ming Zhang, Wei Tang, Norihiro Kokudo. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. World Journal of Gastroenterology 2014; 20(34): 12171-12181 doi: 10.3748/wjg.v20.i34.12171
|
| 3 |
Sabine Heublein, Doris Mayr, Markus Egger, Uwe Karsten, Steffen Goletz, Martin Angele, Julia Gallwas, Udo Jeschke, Nina Ditsch. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0152-7
|
| 4 |
Ryukou Izumi, Takahiko Matsushita, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Sakae Tsuda, Hiroshi Hinou, Shin‐Ichiro Nishimura. Microwave‐Assisted Solid‐Phase Synthesis of Antifreeze Glycopeptides. Chemistry – A European Journal 2013; 19(12): 3913 doi: 10.1002/chem.201203731
|
| 5 |
Shobith Rangappa, Gerard Artigas, Risho Miyoshi, Yasuhiro Yokoi, Shun Hayakawa, Fayna Garcia-Martin, Hiroshi Hinou, Shin-Ichiro Nishimura. Effects of the multiple O-glycosylation states on antibody recognition of the immunodominant motif in MUC1 extracellular tandem repeats. MedChemComm 2016; 7(6): 1102 doi: 10.1039/C6MD00100A
|
| 6 |
Megumi Kiyoi, Tatsuya Yoshimasu, Fuminori Ota, Koma Naito, Yoshimitsu Hirai, Yoshitaka Okamura. Two cases of rectal cancer metastasizing to the lung with a high serum KL-6 level. The Journal of the Japanese Associtation for Chest Surgery 2008; 22(6): 933 doi: 10.2995/jacsurg.22.933
|
| 7 |
Sonosuke Tanaka, Noboru Hattori, Nobuhisa Ishikawa, Hiroyasu Shoda, Atsushi Takano, Ryohei Nishino, Morihito Okada, Koji Arihiro, Kouki Inai, Hironobu Hamada, Akihito Yokoyama, Nobuoki Kohno. Krebs von den Lungen‐6 (KL‐6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer. International Journal of Cancer 2012; 130(2): 377 doi: 10.1002/ijc.26007
|
| 8 |
K. Veluraja, K.N. Vennila, K. Umamakeshvari, A. Jasmine, D. Velmurugan. Structural investigation of porcine stomach mucin by X-ray fiber diffraction and homology modeling. Biochemical and Biophysical Research Communications 2011; 406(4): 570 doi: 10.1016/j.bbrc.2011.02.092
|
| 9 |
Yoshinori Inagaki, Yasuji Seyama, Kiyoshi Hasegawa, Wei Tang, Norihiro Kokudo. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas. Drug Discoveries & Therapeutics 2014; 8(4): 173 doi: 10.5582/ddt.2014.01027
|
| 10 |
Axel Van Meer, Jacques Gilis, Baptiste Oosterlinck, Timon Vandamme, Joris De Man, Benedicte Y. De Winter, Annemieke Smet. Clinicopathological and prognostic significance of mucin signatures in lower gastrointestinal cancer–a systematic review and meta-analysis. British Journal of Cancer 2025; doi: 10.1038/s41416-025-03297-7
|
| 11 |
H.L. Xu, Y. Inagaki, Y. Seyama, Y. Sugawara, N. Kokudo, M. Nakata, F.S. Wang, W. Tang. Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion. Life Sciences 2009; 85(9-10): 395 doi: 10.1016/j.lfs.2009.07.004
|
| 12 |
Naoe Yanagisawa, Naohiko Koide, Harunari Fukai, Yoshinori Koyama, Yuu Ogihara, Maki Ohya. Two cases of gastric cancer with elevated serum levels of KL-6. Surgical Case Reports 2024; 10(1) doi: 10.1186/s40792-024-01883-0
|
| 13 |
Hiroyuki Tsuchie, Seiya Miyamoto, Yoichi Kataoka, Seietsu Senma, Yuichiro Narita, Yuji Hatakeyama, Moto Kobayashi, Kana Sasaki, Yoichi Shimada. Rheumatoid Arthritis with High Serum KL-6 Complicating Malignant Tumor: Two Case Reports. Open Journal of Orthopedics 2015; 5(03): 41 doi: 10.4236/ojo.2015.53006
|
| 14 |
Chao Li, Tao Liu, Libin Yin, Didi Zuo, Yuyang Lin, Lei Wang. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer. Medicine 2019; 98(9): e14659 doi: 10.1097/MD.0000000000014659
|
| 15 |
Naoki Ohyabu, Hiroshi Hinou, Takahiko Matsushita, Ryukou Izumi, Hiroki Shimizu, Keiko Kawamoto, Yoshito Numata, Hiroko Togame, Hiroshi Takemoto, Hirosato Kondo, Shin-Ichiro Nishimura. An Essential Epitope of Anti-MUC1 Monoclonal Antibody KL-6 Revealed by Focused Glycopeptide Library. Journal of the American Chemical Society 2009; 131(47): 17102 doi: 10.1021/ja903361f
|
| 16 |
Tae Mogami, Haruya Saji, Naho Yokota, Rie Suzuki, Akiko Sukegawa, Mikiko Asai-Sato, Etsuko Miyagi, Fumiki Hirahara. Serum KL-6 for diagnosis of ovarian carcinoma associated with dermatomyositis: two case reports and characteristic clinicopathological factors. International Cancer Conference Journal 2012; 1(2): 83 doi: 10.1007/s13691-012-0016-3
|
| 17 |
Teresa M. Horm, Joyce A. Schroeder. MUC1 and metastatic cancer. Cell Adhesion & Migration 2013; 7(2): 187 doi: 10.4161/cam.23131
|
| 18 |
Subhankar Chakraborty, Maneesh Jain, Aaron R Sasson, Surinder K Batra. MUC4 as a diagnostic marker in cancer. Expert Opinion on Medical Diagnostics 2008; 2(8): 891 doi: 10.1517/17530059.2.8.891
|
| 19 |
Huanli Xu, Yoshinori Inagaki, Yasuji Seyama, Kiyoshi Hasegawa, Yasuhiko Sugawara, Guanhua Du, Fengshan Wang, Wei Tang, Norihiro Kokudo. Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression. Life Sciences 2011; 88(23-24): 1063 doi: 10.1016/j.lfs.2011.03.021
|
| 20 |
A. Seko, T. Ohkura, H. Ideo, K. Yamashita. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: Possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. Glycobiology 2012; 22(2): 181 doi: 10.1093/glycob/cwr118
|
| 21 |
Yunhui Zeng, Qiongwen Zhang, Yujie Zhang, Minxun Lu, Yang Liu, Tianying Zheng, Shijian Feng, Meiqin Hao, Huashan Shi, Pankaj K Singh. MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies. PLOS ONE 2015; 10(9): e0138049 doi: 10.1371/journal.pone.0138049
|
| 22 |
Yaron Niv, Theodore Rokkas. Mucin Expression in Colorectal Cancer (CRC). Journal of Clinical Gastroenterology 2019; 53(6): 434 doi: 10.1097/MCG.0000000000001050
|
| 23 |
Yasuni Nakanuma, Tsuneyuki Uchida, Yasunori Sato, Katsuhiko Uesaka. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. Human Pathology 2017; 60: 46 doi: 10.1016/j.humpath.2016.10.003
|